GRAIL Completes Spin-Off from Illumina, Launches Groundbreaking Cancer Screening Technology
GRAIL, Inc. , a leading healthcare company dedicated to early cancer detection, has announced the completion of its spin-off from Illumina (NASDAQ: ILMN). GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol "GRAL."